EKSO - Ekso Bionics Holdings Inc Profile, Share Price, Market Analysis, Charts, Fundamentals

Company Name, Ticker, Industry, else..

Ekso Bionics Holdings Inc (NASDAQ: EKSO)

Sector • Capital Goods Industry • Industrial Machinery and Components

Industry • Industrial Machinery and Components

Sector • Capital Goods

Price: $11.8000 $11.80

Day's High:	$11.649999618530273	Week Perf:	3.15 %
Day's Low:	$ 11.65	30 Day Perf:	21.03 %
Volume (M):	95,135	52 Wk High:	$ 13.50
Volume (M$):	$ 0	52 Wk Avg:	$7.62
Open:	$11.40	52 Wk Low:	$3.50

EKSO Charts & Quotes

EKSO Charts & Quotes

Ekso Bionics Holdings Inc Company Profile

Company's Segments

Market Capitalization (Millions $)	42
Shares Outstanding (Millions)	4
Employees	31
Revenues (TTM) (Millions $)	11
Net Income (TTM) (Millions $)	-16
Cash Flow (TTM) (Millions $)	-1
Capital Exp. (TTM) (Millions $)	27

Business Description

Ekso Bionics Holdings Inc is a leading company in the field of exoskeleton technology. They design and develop wearable robotic devices that assist individuals with mobility impairments. Their exoskeletons are designed to enable individuals with lower limb paralysis or weakness to stand, walk, and regain their independence. The company's products have been used in the healthcare industry and also have potential applications in industries such as construction and manufacturing. Ekso Bionics is dedicated to improving the quality of life for individuals with limited mobility through their innovative exoskeleton technology.

Company Address: 101 Glacier Point, Suite A Zagreb 94901 City of Zagreb
Company Phone Number: 984-1761 Stock Exchange / Ticker: NASDAQ EKSO

Reports on Competition

Suppliers At a Glance

Stock Performances by Major Competitors

5 Days	Decrease / Increase

AVMR		%
LFWD		0.28%
• View Complete Report

Ekso Bionics Holdings Inc News

Management Announcement

Ekso Bionics Sets the Stage for Record Revenues in Q4 2024 Amidst Strategic Financing Initiatives

Published Mon, Jan 13 2025 1:01 PM UTC

In an impressive display of perseverance and innovation, Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) has made significant strides in its financial trajectory and product development. The company recently reported preliminary results indicating a remarkable upward trend in revenues for the fourth quarter of 2024, projecting an all-time high that positions it as a leader in the...

Financing Agreement

Ekso Bionics Raises $6 Million to Empower the Future of Mobility through Exoskeleton Innovation,

Published Fri, Aug 30 2024 2:43 AM UTC

Ekso Bionics: Revolutionizing Exoskeleton Technology through a $6.0 Million Public Offering
San Rafael, California - Leading exoskeleton technology company, Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), recently announced the pricing of a highly anticipated underwritten public offering. The offering, which includes a total of 6,000,000 units and pre-funded units, is expect...

Management Announcement

Ekso Bionics Makes Strides in Exoskeleton Technology with CMS Reimbursement and Accessible Healthcare Program,

Published Tue, Aug 20 2024 12:00 PM UTC

Ekso Bionics Makes Strides with CMS Reimbursement and Launches EksoHealth Personal Program
Ekso Bionics Holdings Inc, a leading exoskeleton technology company, has recently announced the receipt of initial reimbursement from the Centers for Medicare & Medicaid Services (CMS) for its Ekso Indego Personal exoskeleton. This marks a significant milestone for the company...

Partnership

title Exoskeletons Revolutionize Rehabilitation Collaborative Leap Towards Enhanced Patient Lives

Published Tue, Jun 25 2024 12:01 PM UTC

Advancing Rehabilitation Technology: Ekso Bionics and Shepherd Center Form Research PartnershipIn a bid to revolutionize rehabilitation and enhance patient outcomes, Ekso Bionics, a leading developer of exoskeleton technology, has announced a promising research partnership with the renowned Shepherd Center. The collaboration aims to expand the use of EksoNR and Ekso Indego d...

Product Service News

Ekso Bionics Secures Medicare Reimbursement for Ekso Indego Personal Exoskeleton

Published Fri, Apr 12 2024 12:00 PM UTC

Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego PersonalSAN RAFAEL, Calif., April 12, 2024 - Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading provider of exoskeleton technology for medical and industrial applications, is pleased to announce a significant milestone in its...

Fundamental Analysis

Valuation	Current
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	3.78
Price to Sales (Expected)	-
Price to Book	0.23
PEG (TTM)	-

Financial Strength	Current
Quick Ratio	0.11
Working Capital Ratio	0.51
Leverage Ratio (MRQ)	0.83
Total Debt to Equity	0.02
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

Per Share	Current
Earnings (TTM)	-5.75 $
Revenues (TTM)	3.12 $
Cash Flow (TTM)	-
Cash	2.71 $
Book Value	50.53 $
Dividend (TTM)	0 $

Efficiency	Current
Revenue per Employee (TTM)	358,484
Net Income per Employee (TTM)	-506,097
Receivable Turnover Ratio (TTM)	1.46
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.11

Profitability Ratios	Current
Gross Margin (MRQ)	51.78 %
Operating Margin (MRQ)	-270.88 %
Net Margin (MRQ)	-331.97 %
Net Cash Flow Margin (MRQ)	0 %
Effective Tax Rate (TTM)	-

Management Effectiveness	Current
Return On Assets (TTM)	-
Return On Investment (TTM)	-
Return On Equity (TTM)	-
Dividend Yield	-
Pay out Ratio (TTM)	-

Valuation
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	3.78
Price to Sales (Expected)	-
Price to Book	0.23
PEG (TTM)	-

Per Share
Earnings (TTM)	-5.75 $
Revenues (TTM)	3.12 $
Cash Flow (TTM)	-
Cash	2.71 $
Book Value	50.53 $
Dividend (TTM)	0 $

Financial Strength
Quick Ratio	0.11
Working Capital Ratio	0.51
Leverage Ratio (MRQ)	0.83
Total Debt to Equity	0.02
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

Efficiency
Revenue per Employee (TTM)	358,484
Net Income per Employee (TTM)	-506,097
Receivable Turnover Ratio (TTM)	1.46
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.11

Profitability Ratio
Gross Margin (MRQ)	51.78 %
Operating Margin (MRQ)	-270.88 %
Net Margin (MRQ)	-331.97 %
Net Cash Flow Margin (MRQ)	0 %
Effective Tax Rate (TTM)	-

Management Effectiveness
Return On Assets (TTM)	-16.2 %
Return On Investment (TTM)	-22.68 %
Return On Equity (TTM)	-31.25 %
Dividend Yield	-
Pay out Ratio (TTM)	-

Ekso Bionics Holdings Inc's Segments


Product Ekso Health	64.8 %	of total Revenue
Service Ekso Health	28.64 %	of total Revenue
Subscription Ekso Health	3.28 %	of total Revenue
Product and Service Other Ekso Health	6.51 %	of total Revenue
UNITED STATES	73.92 %	of total Revenue
Americas Other	1.01 %	of total Revenue
Americas	74.93 %	of total Revenue
FRANCE	9.98 %	of total Revenue
ITALY	1.25 %	of total Revenue
EMEA Other	15.14 %	of total Revenue
EMEA	26.37 %	of total Revenue
APAC Other	1.93 %	of total Revenue
Asia Pacific	1.93 %	of total Revenue

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.